| 1 |
34159611 | Use of plerixafor to mobilize haematopoietic progenitor cells in healthy donors. | 2022 Jan |
1 |
| 2 |
34801430 | Plerixafor strategies for autologous hematopoietic cell transplant mobilization: A comparison of efficacy and cost. | 2022 Apr |
2 |
| 3 |
33028987 | Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial. | 2021 Mar |
1 |
| 4 |
33483284 | Addition of plerixafor to G-CSF in poor mobilizing healthy related donors overcame mobilization failure: An observational case series on behalf of the Grupo Español de Trasplante Hematopoyético (GETH). | 2021 Apr |
2 |
| 5 |
33682959 | Plerixafor added to G-CSF allows mobilization of a sufficient number of hematopoietic progenitors without impacting the efficacy of TCR-alpha/beta depletion in pediatric haploidentical and genoidentical donors failing to mobilize with G-CSF alone. | 2021 Aug |
1 |
| 6 |
33710672 | Cost saving, patient centered algorithm for progenitor cell mobilization for autologous hematopoietic cell transplantation. | 2021 Aug |
2 |
| 7 |
33753907 | Chemotherapy-based versus chemotherapy-free stem cell mobilization (± plerixafor) in multiple myeloma patients: an Italian cost-effectiveness analysis. | 2021 Aug |
4 |
| 8 |
33781522 | Low-Dose Cyclophosphamide versus Intermediate-High-Dose Cyclophosphamide versus Granulocyte Colony-Stimulating Factor Alone for Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Multicenter Retrospective Study. | 2021 Mar |
1 |
| 9 |
34104027 | Use of Plerixafor for Stem Cell Mobilization in the Setting of Autologous and Allogeneic Stem Cell Transplantations: An Update. | 2021 |
2 |
| 10 |
34490994 | Single-center results reporting improved hematopoietic stem cell mobilization success in pediatric and young adult patients with solid tumors and lymphoma. | 2021 Nov |
3 |
| 11 |
32014363 | Inferior prognosis in poor mobilizing myeloma patients. | 2020 Jun |
1 |
| 12 |
32499108 | A comparison of chemo-free strategy with G-CSF plus plerixafor on demand versus intermediate-dose cyclophosphamide and G-CSF as PBSC mobilization in newly diagnosed multiple myeloma patients: An Italian explorative cost Analysis. | 2020 Oct |
1 |
| 13 |
33204611 | Plerixafor on-demand in association with low-dose cyclophosphamide and G-CSF in the mobilization of patients with multiple myeloma: High effectiveness, low toxicity, and affordable cost. | 2020 |
1 |
| 14 |
30428338 | The case for plerixafor to replace filgrastim as the optimal agent to mobilize peripheral blood donors for allogeneic hematopoietic cell transplantation. | 2019 Feb |
1 |
| 15 |
30642286 | Optimal chemo-mobilization for the collection of peripheral blood stem cells in patients with multiple myeloma. | 2019 Jan 14 |
1 |
| 16 |
30828151 | Benefits of Pre-harvest Peripheral Blood CD34 Counts Guided Single Dose Therapy with PLERIXAFOR in Autologous Hematopoietic Stem Cell Transplantation: A Retrospective Study at a Tertiary Care Institute in India. | 2019 Jan |
1 |
| 17 |
30871977 | Etoposide + Granulocyte Colony-Stimulating Factor and Optional Plerixafor in Patients Who Failed Chemomobilization with or without Plerixafor. | 2019 Jul |
2 |
| 18 |
31068511 | [Efficacy of plerixafor in autologous peripheral blood stem cell collection]. | 2019 |
1 |
| 19 |
31112940 | Proteomic Profiling of Signaling Networks Modulated by G-CSF/Plerixafor/Busulfan-Fludarabine Conditioning in Acute Myeloid Leukemia Patients in Remission or with Active Disease prior to Allogeneic Stem Cell Transplantation. | 2019 |
2 |
| 20 |
31363366 | Efficacy and safety of plerixafor for hematopoietic stem cell mobilization for autologous transplantation in patients with non-Hodgkin lymphoma and multiple myeloma: A systematic review and meta-analysis. | 2019 Aug |
1 |
| 21 |
31566813 | An updated single center experience with plerixafor and granulocyte colony-stimulating factor for stem cell mobilization in light chain amyloidosis. | 2019 Dec |
1 |
| 22 |
29191663 | Impact of Single-Dose Plerixafor as an Adjunct to Granulocyte Colony-Stimulating Factor-Based Peripheral Blood Stem Cell Mobilization on the Graft Composition and Outcome for T Cell-Replete Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: A Comparative Study. | 2018 Mar |
1 |
| 23 |
27578390 | Plerixafor as preemptive strategy results in high success rates in autologous stem cell mobilization failure. | 2017 Aug |
3 |
| 24 |
27859332 | Patients' outcome after rescue plerixafor administration for autologous stem cell mobilization: a single-center retrospective analysis. | 2017 Jan |
4 |
| 25 |
28034992 | Plerixafor and G-CSF combination mobilizes hematopoietic stem and progenitors cells with a distinct transcriptional profile and a reduced in vivo homing capacity compared to plerixafor alone. | 2017 Apr |
1 |
| 26 |
28476490 | Phase I/II Study of Intravenous Plerixafor Added to a Mobilization Regimen of Granulocyte Colony-Stimulating Factor in Lymphoma Patients Undergoing Autologous Stem Cell Collection. | 2017 Aug |
2 |
| 27 |
29153350 | Management of mobilization failure in 2017. | 2017 Dec |
1 |
| 28 |
26726942 | Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for stem cell mobilization in multiple myeloma: efficacy and cost analysis study. | 2016 Apr |
4 |
| 29 |
26969772 | Hematopoietic progenitor cell mobilization for autologous transplantation - a literature review. | 2016 Jan-Feb |
2 |
| 30 |
27103979 | The High Effect of Chemomobilization with High-Dose Etopside + Granulocyte-Colony Stimulating Factor in Autologous Hematopoietic Peripheral Blood Stem Cell Transplantation: A Single Center Experience. | 2016 Mar 17 |
1 |
| 31 |
27245311 | Autologous Stem Cell Mobilization in the Age of Plerixafor. | 2016 Jul |
3 |
| 32 |
27355397 | Plerixafor injection: a hematopoietic stem cell mobilizer in non-Hodgkin lymphoma and multiple myeloma. | 2016 Aug |
1 |
| 33 |
27374031 | [Mobilization of peripheral blood stem cells with plerixafor in poor mobilizer patients]. | 2016 Sep 2 |
5 |
| 34 |
24884311 | Role of plerixafor in autologous stem cell mobilization with vinorelbine chemotherapy and granulocyte-colony stimulating factor in patients with myeloma: a phase II study (PAV-trial). | 2015 Mar |
2 |
| 35 |
25578474 | HIF-1α is required for hematopoietic stem cell mobilization and 4-prolyl hydroxylase inhibitors enhance mobilization by stabilizing HIF-1α. | 2015 Jun |
1 |
| 36 |
25641128 | Evaluation of Dutch guideline for just-in-time addition of plerixafor to stem cell mobilization in patients who fail with granulocyte-colony-stimulating factor. | 2015 May |
1 |
| 37 |
25721167 | Plerixafor on demand in ten healthy family donors as a rescue strategy to achieve an adequate graft for stem cell transplantation. | 2015 Aug |
1 |
| 38 |
25751646 | G-CSF plus preemptive plerixafor vs hyperfractionated CY plus G-CSF for autologous stem cell mobilization in multiple myeloma: effectiveness, safety and cost analysis. | 2015 Jun |
1 |
| 39 |
27429863 | Effectiveness of AMD3100 in treatment of leukemia and solid tumors: from original discovery to use in current clinical practice. | 2015 |
2 |
| 40 |
23656194 | Peripheral blood CD34+ cell monitoring after cyclophosphamide and granulocyte-colony-stimulating factor: an algorithm for the pre-emptive use of plerixafor. | 2014 Feb |
1 |
| 41 |
23781769 | Factors affecting successful mobilization with plerixafor: an Italian prospective survey in 215 patients with multiple myeloma and lymphoma. | 2014 Feb |
2 |
| 42 |
23927398 | Algorithms for early identification of poor mobilization and for on-demand use of plerixafor in patients mobilized by chemotherapy and granulocyte-colony stimulating factor. | 2014 Mar |
1 |
| 43 |
23944772 | Addition of plerixafor for CD34+ cell mobilization in six healthy stem cell donors ensured satisfactory grafts for transplantation. | 2014 Apr |
1 |
| 44 |
24117899 | Partial engraftment following plerixafor rescue after failed sibling donor peripheral blood stem cell harvest. | 2014 May |
3 |
| 45 |
24128272 | Prospective study of mobilization kinetics up to 18 hours after late-afternoon dosing of plerixafor. | 2014 May |
2 |
| 46 |
24138497 | Plerixafor on-demand combined with chemotherapy and granulocyte colony-stimulating factor: significant improvement in peripheral blood stem cells mobilization and harvest with no increase in costs. | 2014 Jan |
2 |
| 47 |
24317127 | Plerixafor 'on demand': results of a strategy based on peripheral blood CD34+ cells in lymphoma patients at first or subsequent mobilization with chemotherapy+G-CSF. | 2014 Mar |
1 |
| 48 |
24625457 | Plerixafor added to G-CSF-supported paclitaxel-ifosfamide-cisplatin salvage chemotherapy enhances mobilization of adequate numbers of hematopoietic stem cells for subsequent autografting in hard-to-mobilize patients with relapsed/refractory germ-cell tumors: a single-center experience. | 2014 Aug |
1 |
| 49 |
24660786 | Efficacy of just-in-time plerixafor rescue for Hodgkin's lymphoma patients with poor peripheral blood stem cell mobilization. | 2014 Aug |
1 |
| 50 |
24797182 | An effective mobilization strategy for lymphoma patients after failed upfront mobilization with plerixafor. | 2014 Aug |
2 |